Fluorescence endoscopic detection of murine colitis-associated colon cancer by topically applied enzymatically rapid-activatable probe

Gut

Volumn 62, Issue 8, 2013, Pages 1179-1186

  Mitsunaga, Makoto ^a   Kosaka, Nobuyuki ^a   Choyke, Peter L ^a   Young, Matthew R ^b   Dextras, Christopher R ^b   Saud, Shakir M ^a,b   Colburn, Nancy H ^b   Sakabe, Masayo ^c   Nagano, Tetsuo ^c   Asanuma, Daisuke ^c   Urano, Yasuteru ^c   Kobayashi, Hisataka ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; DEXTRAN SULFATE; FLUORESCENT DYE; GAMMA GLUTAMYL HYDROXYMETHYL RHODAMINE GREEN; GAMMA GLUTAMYLTRANSFERASE; RHODAMINE; TUMOR MARKER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CANCER SCREENING; CELL LINE; COLITIS; COLITIS ASSOCIATED COLON CANCER; COLON BIOPSY; COLON CANCER; COLONOSCOPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPLASIA; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; FLUORESCENCE MICROSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMAGE GUIDED BIOPSY; INFLAMMATORY INFILTRATE; INTESTINE CELL; MICROSCOPY; MOLECULAR PROBE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPEAT PROCEDURE; SCREENING FLUORESCENCE COLONOSCOPY; TUMOR BIOPSY;

ACTIVATABLE PROBE; CANCER; COLITIS-ASSOCIATED COLON CANCER; COLORECTAL CANCER; COLORECTAL METASTASES; FLUORESCENCE ENDOSCOPY; GASTROINTESTINAL ENDOSCOPY; IMAGE ANALYSIS; IMAGING; INFLAMMATORY BOWEL DISEASE; LIVER IMAGING; LIVER METASTASES; OPTICAL MOLECULAR IMAGING;

ADENOCARCINOMA; ADMINISTRATION, TOPICAL; ANIMALS; BIOPSY; COLITIS; COLON; COLONIC NEOPLASMS; COLONOSCOPY; DISEASE MODELS, ANIMAL; EARLY DETECTION OF CANCER; FLUORESCENT DYES; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; PRECANCEROUS CONDITIONS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84880302780     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-301795     Document Type: Article

References (37)

1. Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 2006;23:1097-104.
2. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526-35.
3. Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 2003;18(Suppl 2):1-5.
4. Bernstein CN, Blanchard JF, Kliewer E, et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 2001;91:854-62.
5. Lakatos L, Mester G, Erdelyi Z, et al. Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study. Inflamm Bowel Dis 2006;12:205-11.
6. Jess T, Loftus EV Jr, Velayos FS, et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. Gastroenterology 2006;130:1039-46.
7. Eaden JA, Mayberry JF. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 2002;51(Suppl 5):V10-12.
8. Anon. The role of colonoscopy in the management of patients with inflammatory bowel disease. American Society for Gastrointestinal Endoscopy. Gastrointest Endosc 1998;48:689-90.
9. Lutgens MW, Vleggaar FP, Schipper ME, et al. High frequency of early colorectal cancer in inflammatory bowel disease. Gut 2008;57:1246-51.
10. Rutter MD, Saunders BP, Schofield G, et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004;53:256-60.
11. Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003;124:880-8.
12. Matsumoto T, Kudo T, Jo Y, et al. Magnifying colonoscopy with narrow band imaging system for the diagnosis of dysplasia in ulcerative colitis: a pilot study. Gastrointest Endosc 2007;66:957-65.
13. van den Broek FJ, Fockens P, van Eeden S, et al. Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomised comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions. Gut 2008;57:1083-9.
14. Kiesslich R, Goetz M, Lammersdorf K, et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology 2007;132:874-82.
15. Pompella A, De Tata V, Paolicchi A, et al. Expression of gamma-glutamyltransferase in cancer cells and its significance in drug resistance. Biochem Pharmacol 2006;71:231-8.
16. Mahmood U, Weissleder R. Near-infrared optical imaging of proteases in cancer. Mol Cancer Ther 2003;2:489-96.
17. Bremer C, Tung CH, Weissleder R. Molecular imaging of MMP expression and therapeutic MMP inhibition. Acad Radiol 2002;9(Suppl 2):S314-15.
18. Urano Y, Asanuma D, Hama Y, et al. Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes. Nat Med 2009;15:104-9.
19. Hama Y, Urano Y, Koyama Y, et al. A target cell-specific activatable fluorescence probe for in vivo molecular imaging of cancer based on a self-quenched avidin-rhodamine conjugate. Cancer Res 2007;67:2791-9.
20. Urano Y, Sakabe M, Kosaka N, et al. Rapid cancer detection by topically spraying a gamma-glutamyltranspeptidase-activated fluorescent probe. Sci Transl Med 2011;3:110ra119.
21. Kamiya M, Asanuma D, Kuranaga E, et al. β-Galactosidase fluorescence probe with improved cellular accumulation based on a spirocyclized rhodol scaffold. J Am Chem Soc 2011;133:12960-3.
22. Robbins PF, Kantor JA, Salgaller M, et al. Transduction and expression of the human carcinoembryonic antigen gene in a murine colon carcinoma cell line. Cancer Res 1991;51:3657-62.
23. Young MR, Ileva LV, Bernardo M, et al. Monitoring of tumor promotion and progression in a mouse model of inflammation-induced colon cancer with magnetic resonance colonography. Neoplasia 2009;11:237-46, 1p following 246.
24. Mitsunaga M, Kosaka N, Kines RC, et al. In vivo longitudinal imaging of experimental human papillomavirus infection in mice with a multicolor fluorescence mini-endoscopy system. Cancer Prev Res (Phila) 2011;4:767-73.
25. Ogawa M, Kosaka N, Choyke PL, et al. H-type dimer formation of fluorophores: a mechanism for activatable, in vivo optical molecular imaging. ACS Chem Biol 2009;4:535-46.
26. Kosaka N, Ogawa M, Choyke PL, et al. In vivo stable tumor-specific painting in various colors using dehalogenase-based protein-tag fluorescent ligands. Bioconjug Chem 2009;20:1367-74.
27. Melville DM, Jass JR, Morson BC, et al. Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome. Hum Pathol 1989;20:1008-14.
28. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983;14:931-68.
29. Boivin GP, Washington K, Yang K, et al. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 2003;124:762-77.
30. Kishimoto H, Zhao M, Hayashi K, et al. In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation. Proc Natl Acad Sci U S A 2009;106:14514-17.
31. Kishimoto H, Urata Y, Tanaka N, et al. Selective metastatic tumor labeling with green fluorescent protein and killing by systemic administration of telomerase-dependent adenoviruses. Mol Cancer Ther 2009;8:3001-8.
32. Kishimoto H, Aki R, Urata Y, et al. Tumor-selective, adenoviral-mediated GFP genetic labeling of human cancer in the live mouse reports future recurrence after resection. Cell Cycle 2011;10:2737-41.
33. Bouvet M, Hoffman RM. Glowing tumors make for better detection and resection. Sci Transl Med 2011;3:110fs10.
34. Hanigan MH, Frierson HF Jr, Brown JE, et al. Human ovarian tumors express gamma-glutamyl transpeptidase. Cancer Res 1994;54:286-90.
35. Yao D, Jiang D, Huang Z, et al. Abnormal expression of hepatoma specific gamma-glutamyl transferase and alteration of gamma-glutamyl transferase gene methylation status in patients with hepatocellular carcinoma. Cancer 2000;88: 761-9.
36. Schafer C, Fels C, Brucke M, et al. Gamma-glutamyl transferase expression in higher-grade astrocytic glioma. Acta Oncol 2001;40:529-35.
37. Borkje B, Odegaard S, Skagen DW, et al. Enzyme activities in biopsy specimens from human gastric mucosa. Scand J Gastroenterol 1986;21:1051-7.